q3 adjusted earnings per share $2.77.
q3 revenue $628.3 million versus refinitiv ibes estimate of $619.4 million.
sees fy 2021 adjusted earnings per share $0.07 to $00.15 from continuing operations.
compname announces $500 million agreement to acquire z-medica.
compname reports fourth quarter and full year 2021 results; announces expanded indication for ezio.
q3 adjusted earnings per share $2.77.
qtrly revenue fell 12 percent to $78 million.
compname reports q3 adjusted earnings per share $0.13.
q3 revenue $135.7 million versus refinitiv ibes estimate of $135 million.
q3 adjusted earnings per share $2.77.
qtrly constant currency revenue growth of 4% versus 4% in q3.
qtrly adjusted gross profit of $359.6 million versus $380 million.
q3 revenue rose 0.4 percent to $375 million.
compname reports q2 2021 results and announces 3% underlying decline in revenue.
compname reports q3 earnings per share $40.00.
q3 revenue $93.2 million versus refinitiv ibes estimate of $93 million.
